1541 related articles for article (PubMed ID: 2864480)
1. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.
Pellow S; Chopin P; File SE; Briley M
J Neurosci Methods; 1985 Aug; 14(3):149-67. PubMed ID: 2864480
[TBL] [Abstract][Full Text] [Related]
2. The use of a plus-maze to measure anxiety in the mouse.
Lister RG
Psychopharmacology (Berl); 1987; 92(2):180-5. PubMed ID: 3110839
[TBL] [Abstract][Full Text] [Related]
3. Ethopharmacological analysis of rat behavior on the elevated plus-maze.
Cruz AP; Frei F; Graeff FG
Pharmacol Biochem Behav; 1994 Sep; 49(1):171-6. PubMed ID: 7816869
[TBL] [Abstract][Full Text] [Related]
4. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
[TBL] [Abstract][Full Text] [Related]
5. Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety.
Weiss SM; Wadsworth G; Fletcher A; Dourish CT
Neurosci Biobehav Rev; 1998; 23(2):265-71. PubMed ID: 9884119
[TBL] [Abstract][Full Text] [Related]
6. Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol.
Lapin IP
Pharmacol Biochem Behav; 1993 Jan; 44(1):241-3. PubMed ID: 8094251
[TBL] [Abstract][Full Text] [Related]
7. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam.
Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R
Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348
[TBL] [Abstract][Full Text] [Related]
8. Validation of aversion towards open space and height as a measure of anxiety in the genetically based animal model of depression.
Golda V; Petr R
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1990; 33(5):513-27. PubMed ID: 2132725
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and pharmacological validation of the elevated plus maze constructed with transparent walls.
Anseloni VZ; Motta V; Lima G; Brandão ML
Braz J Med Biol Res; 1995 May; 28(5):597-601. PubMed ID: 8555981
[TBL] [Abstract][Full Text] [Related]
10. Higher detection sensitivity of anxiolytic effects of diazepam by ledge-free open arm with opaque walled closed arm elevated plus maze in male rats.
Horii Y; Kawaguchi M
Behav Brain Res; 2015 Nov; 294():131-40. PubMed ID: 26241172
[TBL] [Abstract][Full Text] [Related]
11. Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze.
Wada T; Fukuda N
Psychopharmacology (Berl); 1991; 104(4):444-50. PubMed ID: 1685794
[TBL] [Abstract][Full Text] [Related]
12. Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats.
Fernández-Guasti A; Reyes R; Martínez-Mota L; López-Muñoz FJ
Psychopharmacology (Berl); 2005 Jul; 180(3):399-407. PubMed ID: 15719217
[TBL] [Abstract][Full Text] [Related]
13. Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.
Dawson GR; Crawford SP; Collinson N; Iversen SD; Tricklebank MD
Psychopharmacology (Berl); 1995 Apr; 118(3):316-23. PubMed ID: 7617825
[TBL] [Abstract][Full Text] [Related]
14. Oxycodone decreases anxiety-like behavior in the elevated plus-maze test in male and female rats.
Bruijnzeel AW; Behnood-Rod A; Malphurs W; Chellian R; Caudle RM; Febo M; Setlow B; Neubert JK
Behav Pharmacol; 2022 Sep; 33(6):418-426. PubMed ID: 35947068
[TBL] [Abstract][Full Text] [Related]
15. Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze.
Navarro JF; Maldonado E
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1151-4. PubMed ID: 12452538
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.
Pellow S; File SE
Pharmacol Biochem Behav; 1986 Mar; 24(3):525-9. PubMed ID: 2871560
[TBL] [Abstract][Full Text] [Related]
17. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
18. Antianxiety properties of the angiotensin II antagonist, DUP 753, in the rat using the elevated plus-maze.
Kaiser FC; Palmer GC; Wallace AV; Carr RD; Fraser-Rae L; Hallam C
Neuroreport; 1992 Oct; 3(10):922-4. PubMed ID: 1358253
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.
Guimarães FS; de Aguiar JC; Mechoulam R; Breuer A
Gen Pharmacol; 1994 Jan; 25(1):161-4. PubMed ID: 7913072
[TBL] [Abstract][Full Text] [Related]
20. One-trial tolerance to the effects of chlordiazepoxide in the elevated plus-maze is not due to acquisition of a phobic avoidance of open arms during initial exposure.
Frussa-Filho R; Ribeiro Rde A
Life Sci; 2002 Jun; 71(5):519-25. PubMed ID: 12052436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
